文献速递神经介入DSA

Derivo栓塞装置治疗颅内动脉瘤的有效性与安全性:系统评价与Meta分析

Efficacy and safety of Derivo embolization device in intracranial aneurysms: A systematic review and Meta-Analysis.
PubMed 文献 · Neuroradiology · 2025-08-25

该系统评价与Meta分析纳入13项研究、1125例患者和1338个颅内动脉瘤,评估Derivo栓塞装置的有效性与安全性。汇总完全闭塞率为83%(95%CI 79%-87%),充分闭塞率为92%(95%CI 84%-97%),良好结局率为97%(95%CI 92%-100%);主要缺血性并发症率为1%(95%CI 0%-2%),主要出血性并发症率为0%(95%CI 0%-1%)。

要点

  • Derivo装置汇总完全闭塞率83%、充分闭塞率92%,良好结局率97%。
  • 主要缺血性并发症率1%,主要出血性并发症率0%。
  • 汇总辅助弹簧圈栓塞率为15%(95%CI 7%-26%)。

核心结论

  • Derivo栓塞装置与较高的完全闭塞率和充分闭塞率相关,同时主要缺血性和出血性并发症率较低。

研究设计与样本

  • 系统评价与Meta分析,遵循PRISMA指南,于2025年2月25日检索PubMed、Embase、Scopus和Web of Science,纳入报告Derivo栓塞装置临床和影像学结局的研究共13项、1125例患者、1338个动脉瘤。

诊断标准与关键数值

  • 汇总完全闭塞率为83%(95%CI 79%-87%)。
  • 汇总充分闭塞率为92%(95%CI 84%-97%)。
  • 汇总良好结局率为97%(95%CI 92%-100%)。
  • 汇总辅助弹簧圈栓塞率为15%(95%CI 7%-26%)。
  • 汇总主要缺血性并发症率为1%(95%CI 0%-2%),主要出血性并发症率为0%(95%CI 0%-1%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Derivo embolization device (DED) is a second-generation flow diverter (FD) that has been increasingly used in the management of intracranial aneurysms (IAs). DEDs consist of 48 nitinol wires with an inner platinum core and a blue-colored coating of oxides and oxynitrides, which mitigates these FDs' thrombogenicity. This systematic review and meta-analysis evaluate the efficacy and safety of DED in IAs.

METHODS: On February 25, 2025, a comprehensive search was conducted across PubMed, Embase, Scopus, and Web of Science in accordance with PRISMA guidelines. Studies reporting clinical and radiological outcomes of DED were included.

RESULTS: Thirteen studies involving 1125 patients and 1338 aneurysms were included. The meta-analysis revealed a pooled complete occlusion rate of 83% (95% CI: 79%-87%), an adequate occlusion rate of 92% (95% CI: 84%-97%), and a favorable outcomes rate of 97% (95% CI: 92%-100%). Additionally, the meta-analysis demonstrated a pooled adjuvant coiling rate of 15% (95% CI: 7%-26%), a major ischemic complication rate of 1% (95% CI: 0%-2%), and a major hemorrhagic complication rate of 0% (95% CI: 0%-1%).

CONCLUSION: The current study's findings revealed that DEDs are associated with promising complete and adequate occlusion rates concurrent with low rates of major ischemic and hemorrhagic complications.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Hajikarimloo B, Tos SM, Saha A, et al. Efficacy and safety of Derivo embolization device in intracranial aneurysms: A systematic review and Meta-Analysis. Neuroradiology. 2025. PMID: 40853462. doi:10.1007/s00234-025-03744-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。